| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lead | 68 | 2020 | 880 | 3.470 |
Why?
|
| Aging | 128 | 2024 | 8764 | 1.850 |
Why?
|
| Environmental Exposure | 51 | 2019 | 4528 | 1.160 |
Why?
|
| Forced Expiratory Volume | 45 | 2022 | 1820 | 1.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 29 | 2020 | 3243 | 1.020 |
Why?
|
| Particulate Matter | 26 | 2018 | 2609 | 0.950 |
Why?
|
| Vital Capacity | 32 | 2021 | 984 | 0.890 |
Why?
|
| Patella | 22 | 2019 | 317 | 0.840 |
Why?
|
| Coronary Disease | 20 | 2018 | 5924 | 0.790 |
Why?
|
| Bone and Bones | 32 | 2019 | 2589 | 0.780 |
Why?
|
| Vehicle Emissions | 9 | 2015 | 656 | 0.760 |
Why?
|
| Lung | 35 | 2023 | 10089 | 0.750 |
Why?
|
| Tibia | 25 | 2019 | 1075 | 0.720 |
Why?
|
| Soot | 12 | 2015 | 221 | 0.690 |
Why?
|
| DNA Methylation | 20 | 2022 | 4421 | 0.670 |
Why?
|
| Postural Balance | 2 | 2016 | 639 | 0.640 |
Why?
|
| Air Pollutants | 23 | 2018 | 2900 | 0.640 |
Why?
|
| Longitudinal Studies | 100 | 2023 | 14784 | 0.610 |
Why?
|
| Air Pollution | 19 | 2018 | 2363 | 0.610 |
Why?
|
| Methacholine Chloride | 20 | 2007 | 220 | 0.550 |
Why?
|
| Aged, 80 and over | 133 | 2024 | 59686 | 0.540 |
Why?
|
| Blood Pressure | 38 | 2016 | 8541 | 0.530 |
Why?
|
| Aged | 234 | 2024 | 171562 | 0.530 |
Why?
|
| Environmental Pollutants | 11 | 2018 | 1290 | 0.520 |
Why?
|
| Carbon | 5 | 2018 | 672 | 0.520 |
Why?
|
| Smoking | 54 | 2019 | 9111 | 0.490 |
Why?
|
| Heart Rate | 17 | 2014 | 4218 | 0.490 |
Why?
|
| Boston | 54 | 2018 | 9371 | 0.470 |
Why?
|
| Xenopus | 6 | 2000 | 710 | 0.460 |
Why?
|
| Bronchial Provocation Tests | 17 | 2012 | 216 | 0.460 |
Why?
|
| Glutathione Transferase | 8 | 2014 | 564 | 0.440 |
Why?
|
| Lead Poisoning | 10 | 2014 | 323 | 0.440 |
Why?
|
| Male | 264 | 2024 | 364902 | 0.400 |
Why?
|
| Lung Diseases, Obstructive | 9 | 2001 | 311 | 0.400 |
Why?
|
| Middle Aged | 208 | 2024 | 223491 | 0.390 |
Why?
|
| Temperature | 7 | 2018 | 2235 | 0.380 |
Why?
|
| Personality | 5 | 2014 | 560 | 0.370 |
Why?
|
| Polymorphism, Genetic | 17 | 2016 | 4250 | 0.370 |
Why?
|
| Social Control, Informal | 1 | 2011 | 44 | 0.360 |
Why?
|
| Xenopus Proteins | 6 | 2001 | 435 | 0.360 |
Why?
|
| Epigenesis, Genetic | 11 | 2020 | 3827 | 0.360 |
Why?
|
| Hostility | 4 | 2016 | 185 | 0.340 |
Why?
|
| Bronchial Hyperreactivity | 7 | 2007 | 301 | 0.340 |
Why?
|
| Telephone | 2 | 2011 | 630 | 0.330 |
Why?
|
| Glutathione S-Transferase pi | 5 | 2015 | 99 | 0.330 |
Why?
|
| Intercellular Adhesion Molecule-1 | 6 | 2016 | 1133 | 0.330 |
Why?
|
| Porphobilinogen Synthase | 5 | 2008 | 29 | 0.320 |
Why?
|
| Hypertension | 20 | 2018 | 8615 | 0.320 |
Why?
|
| Nails | 5 | 2022 | 297 | 0.320 |
Why?
|
| Resistance Training | 1 | 2011 | 199 | 0.320 |
Why?
|
| Xenopus laevis | 4 | 2000 | 966 | 0.310 |
Why?
|
| Asthma | 21 | 2019 | 6280 | 0.310 |
Why?
|
| Exercise Therapy | 1 | 2016 | 941 | 0.310 |
Why?
|
| Genetic Predisposition to Disease | 25 | 2020 | 18048 | 0.310 |
Why?
|
| Anger | 4 | 2006 | 405 | 0.310 |
Why?
|
| MMPI | 7 | 2011 | 81 | 0.300 |
Why?
|
| Bronchi | 7 | 2002 | 849 | 0.300 |
Why?
|
| Arsenic | 3 | 2022 | 362 | 0.300 |
Why?
|
| Accidental Falls | 1 | 2016 | 1080 | 0.290 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2010 | 579 | 0.290 |
Why?
|
| Linear Models | 28 | 2020 | 5878 | 0.290 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 5 | 2016 | 692 | 0.290 |
Why?
|
| Embryo, Nonmammalian | 4 | 2000 | 911 | 0.290 |
Why?
|
| Humans | 286 | 2024 | 768393 | 0.280 |
Why?
|
| Cohort Studies | 55 | 2018 | 41795 | 0.280 |
Why?
|
| Cadmium | 4 | 2022 | 217 | 0.280 |
Why?
|
| Muscle Strength | 1 | 2011 | 641 | 0.280 |
Why?
|
| Regression Analysis | 31 | 2017 | 6350 | 0.270 |
Why?
|
| Heart | 10 | 2000 | 4449 | 0.270 |
Why?
|
| Cognition | 9 | 2024 | 7075 | 0.270 |
Why?
|
| Respiratory Function Tests | 12 | 2021 | 1696 | 0.270 |
Why?
|
| Dysostoses | 1 | 2005 | 7 | 0.260 |
Why?
|
| Polymorphism, Single Nucleotide | 26 | 2019 | 16028 | 0.260 |
Why?
|
| Diet | 11 | 2018 | 8090 | 0.260 |
Why?
|
| Leukocyte Count | 8 | 2020 | 1605 | 0.260 |
Why?
|
| Lead Poisoning, Nervous System, Adult | 3 | 2013 | 12 | 0.250 |
Why?
|
| Metals, Heavy | 2 | 2020 | 149 | 0.250 |
Why?
|
| Glycosyltransferases | 1 | 2005 | 114 | 0.240 |
Why?
|
| Combat Disorders | 1 | 2007 | 301 | 0.240 |
Why?
|
| Parkinson Disease | 2 | 2016 | 2895 | 0.240 |
Why?
|
| Veterans | 14 | 2020 | 2671 | 0.230 |
Why?
|
| Adult | 144 | 2021 | 223640 | 0.230 |
Why?
|
| Long Interspersed Nucleotide Elements | 6 | 2012 | 332 | 0.230 |
Why?
|
| Telemedicine | 3 | 2011 | 3107 | 0.230 |
Why?
|
| Oxidative Stress | 9 | 2016 | 3139 | 0.220 |
Why?
|
| Homocysteine | 3 | 2014 | 637 | 0.220 |
Why?
|
| Cognition Disorders | 6 | 2016 | 3985 | 0.220 |
Why?
|
| Neural Tube Defects | 1 | 2005 | 255 | 0.220 |
Why?
|
| Spirometry | 14 | 2020 | 928 | 0.210 |
Why?
|
| Stress, Psychological | 6 | 2015 | 4543 | 0.210 |
Why?
|
| United States Department of Veterans Affairs | 13 | 2019 | 940 | 0.210 |
Why?
|
| Pulmonary Emphysema | 3 | 2017 | 690 | 0.210 |
Why?
|
| Trans-Activators | 4 | 2006 | 2856 | 0.210 |
Why?
|
| Genetic Loci | 4 | 2019 | 2630 | 0.200 |
Why?
|
| Allergens | 5 | 2012 | 1441 | 0.200 |
Why?
|
| Anxiety | 5 | 2016 | 4677 | 0.200 |
Why?
|
| Patient Compliance | 2 | 2010 | 2693 | 0.200 |
Why?
|
| Repressor Proteins | 4 | 2006 | 2986 | 0.200 |
Why?
|
| Body Patterning | 4 | 1999 | 634 | 0.190 |
Why?
|
| Inflammation | 10 | 2016 | 10863 | 0.190 |
Why?
|
| Leukocytes | 4 | 2022 | 2030 | 0.190 |
Why?
|
| Risk Factors | 49 | 2022 | 74962 | 0.190 |
Why?
|
| Helix-Loop-Helix Motifs | 2 | 1998 | 97 | 0.190 |
Why?
|
| Mercury | 2 | 2022 | 289 | 0.190 |
Why?
|
| Adaptation, Psychological | 2 | 2011 | 2663 | 0.190 |
Why?
|
| Ozone | 7 | 2011 | 490 | 0.190 |
Why?
|
| Depression | 6 | 2016 | 8241 | 0.190 |
Why?
|
| Phobic Disorders | 2 | 2001 | 441 | 0.180 |
Why?
|
| Cardiovascular Diseases | 15 | 2022 | 15649 | 0.180 |
Why?
|
| DNA-Binding Proteins | 11 | 2009 | 9614 | 0.180 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2017 | 2258 | 0.180 |
Why?
|
| Social Dominance | 1 | 2000 | 39 | 0.180 |
Why?
|
| Prospective Studies | 36 | 2023 | 54920 | 0.180 |
Why?
|
| Metals | 3 | 2022 | 713 | 0.180 |
Why?
|
| Age Factors | 26 | 2020 | 18471 | 0.180 |
Why?
|
| Retroelements | 2 | 2013 | 162 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2000 | 3612 | 0.170 |
Why?
|
| Iron | 4 | 2018 | 1814 | 0.170 |
Why?
|
| Electrocardiography | 9 | 2014 | 6409 | 0.170 |
Why?
|
| Vertebrates | 2 | 1999 | 227 | 0.170 |
Why?
|
| Humidity | 3 | 2018 | 206 | 0.170 |
Why?
|
| Potassium, Dietary | 1 | 2019 | 103 | 0.170 |
Why?
|
| Veterans Health | 2 | 2018 | 215 | 0.170 |
Why?
|
| Massachusetts | 16 | 2018 | 8902 | 0.160 |
Why?
|
| Genotype | 22 | 2018 | 13042 | 0.160 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2022 | 827 | 0.160 |
Why?
|
| Genetic Linkage | 4 | 2010 | 2342 | 0.160 |
Why?
|
| Respiratory Mechanics | 3 | 2002 | 722 | 0.160 |
Why?
|
| Spectrometry, X-Ray Emission | 9 | 2013 | 143 | 0.150 |
Why?
|
| Case-Control Studies | 25 | 2019 | 22296 | 0.150 |
Why?
|
| Coronary Vasospasm | 1 | 2018 | 81 | 0.150 |
Why?
|
| Animals, Genetically Modified | 2 | 2000 | 1563 | 0.150 |
Why?
|
| Occupations | 3 | 2014 | 519 | 0.150 |
Why?
|
| Lymphocyte Count | 1 | 2020 | 793 | 0.150 |
Why?
|
| Lung Injury | 1 | 2023 | 433 | 0.150 |
Why?
|
| Carrier Proteins | 4 | 2017 | 4936 | 0.150 |
Why?
|
| Heart Conduction System | 3 | 2015 | 1009 | 0.150 |
Why?
|
| Base Sequence | 11 | 2013 | 12422 | 0.150 |
Why?
|
| Transcription Factors | 10 | 2009 | 12166 | 0.140 |
Why?
|
| Swine Diseases | 1 | 2017 | 61 | 0.140 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2010 | 1362 | 0.140 |
Why?
|
| Embryonic Induction | 1 | 1997 | 152 | 0.140 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2010 | 1891 | 0.140 |
Why?
|
| Body Constitution | 5 | 1999 | 273 | 0.140 |
Why?
|
| Transferrin | 1 | 2018 | 285 | 0.140 |
Why?
|
| Temperament | 1 | 2000 | 301 | 0.140 |
Why?
|
| Maximal Midexpiratory Flow Rate | 4 | 2020 | 75 | 0.140 |
Why?
|
| Bronchoconstrictor Agents | 4 | 2002 | 77 | 0.140 |
Why?
|
| Methacholine Compounds | 5 | 1990 | 35 | 0.140 |
Why?
|
| Genome-Wide Association Study | 11 | 2019 | 12778 | 0.140 |
Why?
|
| Hot Temperature | 3 | 2017 | 1440 | 0.140 |
Why?
|
| Pulmonary Fibrosis | 2 | 2019 | 506 | 0.130 |
Why?
|
| Affect | 4 | 2012 | 1501 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2005 | 2593 | 0.130 |
Why?
|
| Autonomic Nervous System | 1 | 2001 | 709 | 0.130 |
Why?
|
| Bronchoconstriction | 2 | 2000 | 141 | 0.130 |
Why?
|
| Sodium, Dietary | 1 | 2019 | 426 | 0.130 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 2014 | 192 | 0.130 |
Why?
|
| Uric Acid | 5 | 2006 | 806 | 0.130 |
Why?
|
| Educational Status | 4 | 1999 | 2518 | 0.130 |
Why?
|
| Respiration | 6 | 1997 | 1667 | 0.130 |
Why?
|
| Food Contamination | 1 | 2017 | 193 | 0.130 |
Why?
|
| Pericarditis | 1 | 2017 | 136 | 0.130 |
Why?
|
| Anthocyanins | 1 | 2016 | 80 | 0.130 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2017 | 224 | 0.130 |
Why?
|
| Models, Molecular | 1 | 2005 | 5404 | 0.130 |
Why?
|
| Fear | 2 | 2016 | 1494 | 0.130 |
Why?
|
| Dermatitis | 1 | 2017 | 203 | 0.120 |
Why?
|
| gamma-Tocopherol | 1 | 2015 | 29 | 0.120 |
Why?
|
| Tocopherols | 1 | 2015 | 44 | 0.120 |
Why?
|
| Homeodomain Proteins | 3 | 2001 | 2429 | 0.120 |
Why?
|
| Respiration Disorders | 2 | 2009 | 366 | 0.120 |
Why?
|
| Skin Tests | 10 | 2012 | 639 | 0.120 |
Why?
|
| Attitude | 1 | 2000 | 772 | 0.120 |
Why?
|
| Occupational Exposure | 3 | 2014 | 1817 | 0.120 |
Why?
|
| Antioxidants | 2 | 2016 | 1673 | 0.120 |
Why?
|
| alpha-Tocopherol | 1 | 2015 | 126 | 0.120 |
Why?
|
| Membrane Proteins | 4 | 2010 | 7880 | 0.120 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 4 | 2011 | 781 | 0.110 |
Why?
|
| Vitamin B Complex | 2 | 2014 | 299 | 0.110 |
Why?
|
| Reference Values | 15 | 2005 | 4941 | 0.110 |
Why?
|
| Angina Pectoris | 2 | 1997 | 960 | 0.110 |
Why?
|
| Tremor | 1 | 2015 | 195 | 0.110 |
Why?
|
| Iron Regulatory Protein 2 | 2 | 2013 | 43 | 0.110 |
Why?
|
| Obesity | 16 | 2013 | 13084 | 0.110 |
Why?
|
| Respiratory Sounds | 3 | 1993 | 702 | 0.110 |
Why?
|
| Multivariate Analysis | 14 | 2015 | 12092 | 0.110 |
Why?
|
| C-Reactive Protein | 5 | 2016 | 3857 | 0.110 |
Why?
|
| Bradycardia | 1 | 2015 | 305 | 0.100 |
Why?
|
| Seasons | 5 | 2017 | 1526 | 0.100 |
Why?
|
| Models, Genetic | 3 | 2020 | 3442 | 0.100 |
Why?
|
| Molecular Sequence Data | 8 | 2005 | 17626 | 0.100 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2010 | 1114 | 0.100 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2015 | 348 | 0.100 |
Why?
|
| Olfaction Disorders | 1 | 2015 | 226 | 0.100 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 1998 | 848 | 0.100 |
Why?
|
| Heme Oxygenase-1 | 3 | 2014 | 365 | 0.100 |
Why?
|
| Posture | 4 | 1986 | 956 | 0.100 |
Why?
|
| Lung Diseases | 3 | 2016 | 1925 | 0.100 |
Why?
|
| Potassium | 2 | 2019 | 1318 | 0.100 |
Why?
|
| Receptors, Calcitriol | 1 | 2015 | 361 | 0.100 |
Why?
|
| Proportional Hazards Models | 9 | 2016 | 12558 | 0.100 |
Why?
|
| Socioeconomic Factors | 5 | 2013 | 7861 | 0.100 |
Why?
|
| Female | 54 | 2024 | 397089 | 0.100 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2018 | 742 | 0.100 |
Why?
|
| Flavonoids | 1 | 2015 | 447 | 0.100 |
Why?
|
| Young Adult | 21 | 2018 | 60049 | 0.090 |
Why?
|
| Cold Temperature | 2 | 2017 | 786 | 0.090 |
Why?
|
| Sodium | 2 | 2019 | 1594 | 0.090 |
Why?
|
| Folic Acid | 3 | 2014 | 1336 | 0.090 |
Why?
|
| Endothelium | 2 | 2011 | 768 | 0.090 |
Why?
|
| Personal Satisfaction | 1 | 2016 | 647 | 0.090 |
Why?
|
| Drosophila Proteins | 1 | 2000 | 1712 | 0.090 |
Why?
|
| Body Burden | 6 | 2013 | 158 | 0.090 |
Why?
|
| Craniocerebral Trauma | 1 | 2015 | 495 | 0.090 |
Why?
|
| Neutrophils | 3 | 2020 | 3785 | 0.090 |
Why?
|
| Myogenic Regulatory Factors | 4 | 2001 | 102 | 0.090 |
Why?
|
| Cross-Sectional Studies | 30 | 2015 | 26375 | 0.090 |
Why?
|
| SOXD Transcription Factors | 1 | 2011 | 44 | 0.090 |
Why?
|
| Geographic Information Systems | 1 | 2013 | 283 | 0.090 |
Why?
|
| Incidence | 10 | 2020 | 21544 | 0.090 |
Why?
|
| Cell Communication | 1 | 1998 | 1660 | 0.090 |
Why?
|
| Apolipoproteins E | 3 | 2015 | 1459 | 0.090 |
Why?
|
| Fires | 2 | 1982 | 171 | 0.090 |
Why?
|
| Mental Status Schedule | 4 | 2015 | 315 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2011 | 350 | 0.090 |
Why?
|
| Multigene Family | 2 | 2013 | 1082 | 0.090 |
Why?
|
| Vitamin E | 1 | 2015 | 874 | 0.090 |
Why?
|
| Cardiovascular System | 1 | 1998 | 838 | 0.090 |
Why?
|
| Pulmonary Ventilation | 1 | 2012 | 376 | 0.090 |
Why?
|
| Inhalation Exposure | 2 | 2013 | 431 | 0.090 |
Why?
|
| Gene Expression | 5 | 2019 | 7598 | 0.090 |
Why?
|
| Genetic Association Studies | 2 | 2017 | 2742 | 0.090 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2009 | 44 | 0.090 |
Why?
|
| Occupational Diseases | 3 | 1983 | 1490 | 0.090 |
Why?
|
| Amine Oxidase (Copper-Containing) | 1 | 2009 | 41 | 0.090 |
Why?
|
| Myocardial Ischemia | 3 | 2010 | 2139 | 0.090 |
Why?
|
| Catecholamines | 3 | 1999 | 390 | 0.080 |
Why?
|
| Risk | 11 | 2015 | 9636 | 0.080 |
Why?
|
| Body Weight | 5 | 1995 | 4629 | 0.080 |
Why?
|
| Particle Size | 5 | 2016 | 1653 | 0.080 |
Why?
|
| Lipoprotein Lipase | 1 | 2010 | 133 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 7 | 2013 | 6085 | 0.080 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 2106 | 0.080 |
Why?
|
| Follow-Up Studies | 18 | 2011 | 39407 | 0.080 |
Why?
|
| Receptors, Cell Surface | 4 | 2010 | 2819 | 0.080 |
Why?
|
| Calcium, Dietary | 2 | 2006 | 533 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 4 | 2012 | 5801 | 0.080 |
Why?
|
| Epoxide Hydrolases | 2 | 2007 | 122 | 0.080 |
Why?
|
| Arsenicals | 1 | 2009 | 117 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2010 | 313 | 0.080 |
Why?
|
| Maximal Expiratory Flow Rate | 3 | 2000 | 42 | 0.080 |
Why?
|
| Creatinine | 8 | 2016 | 1915 | 0.080 |
Why?
|
| Immunoglobulin E | 9 | 1997 | 1506 | 0.080 |
Why?
|
| Liver Diseases | 1 | 2017 | 1304 | 0.080 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2007 | 4641 | 0.080 |
Why?
|
| Elastin | 2 | 2008 | 299 | 0.080 |
Why?
|
| Body Composition | 3 | 1997 | 2461 | 0.080 |
Why?
|
| Glutathione | 1 | 2011 | 585 | 0.080 |
Why?
|
| Long QT Syndrome | 2 | 2011 | 472 | 0.080 |
Why?
|
| Insulin | 10 | 1998 | 6607 | 0.080 |
Why?
|
| Muscles | 3 | 2001 | 1582 | 0.080 |
Why?
|
| Hydrocortisone | 2 | 2013 | 1841 | 0.080 |
Why?
|
| Glycine Hydroxymethyltransferase | 1 | 2008 | 31 | 0.080 |
Why?
|
| Phenotype | 12 | 2020 | 16721 | 0.080 |
Why?
|
| Serotonin | 2 | 1993 | 1045 | 0.080 |
Why?
|
| Emphysema | 2 | 2008 | 237 | 0.070 |
Why?
|
| Bone Resorption | 2 | 2001 | 727 | 0.070 |
Why?
|
| United States | 22 | 2020 | 73150 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2010 | 595 | 0.070 |
Why?
|
| Myocardial Infarction | 6 | 1997 | 11516 | 0.070 |
Why?
|
| Receptors, Notch | 2 | 2005 | 751 | 0.070 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2005 | 767 | 0.070 |
Why?
|
| Lipoproteins, LDL | 1 | 2010 | 643 | 0.070 |
Why?
|
| Telomere | 1 | 2014 | 943 | 0.070 |
Why?
|
| Genetic Variation | 5 | 2013 | 6606 | 0.070 |
Why?
|
| Health Status | 2 | 2000 | 4094 | 0.070 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 306 | 0.070 |
Why?
|
| Insulin Resistance | 6 | 1998 | 3981 | 0.070 |
Why?
|
| Tooth Loss | 1 | 2009 | 200 | 0.070 |
Why?
|
| Hypersensitivity | 3 | 2012 | 1173 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 1 | 2016 | 2226 | 0.070 |
Why?
|
| Enzymes | 1 | 2008 | 254 | 0.070 |
Why?
|
| Physical Fitness | 1 | 2011 | 744 | 0.070 |
Why?
|
| beta-Defensins | 1 | 2006 | 59 | 0.070 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2006 | 52 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2016 | 2276 | 0.070 |
Why?
|
| Factor Analysis, Statistical | 2 | 2000 | 1004 | 0.070 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2008 | 276 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2023 | 3804 | 0.070 |
Why?
|
| Genetic Markers | 4 | 2016 | 2604 | 0.070 |
Why?
|
| Mesoderm | 3 | 2000 | 679 | 0.070 |
Why?
|
| Hypersensitivity, Immediate | 5 | 1996 | 349 | 0.070 |
Why?
|
| Rhinitis, Allergic, Seasonal | 2 | 2001 | 104 | 0.070 |
Why?
|
| Time Factors | 17 | 2015 | 40272 | 0.070 |
Why?
|
| Alu Elements | 3 | 2012 | 116 | 0.070 |
Why?
|
| Cats | 2 | 1998 | 978 | 0.070 |
Why?
|
| Morphogenesis | 2 | 2000 | 747 | 0.070 |
Why?
|
| Anxiety Disorders | 1 | 1998 | 2754 | 0.070 |
Why?
|
| Bronchial Diseases | 1 | 1987 | 151 | 0.070 |
Why?
|
| Placental Circulation | 1 | 2006 | 37 | 0.070 |
Why?
|
| Norepinephrine | 8 | 1996 | 900 | 0.070 |
Why?
|
| Self Efficacy | 1 | 2010 | 643 | 0.070 |
Why?
|
| Lipoproteins, HDL | 1 | 2010 | 682 | 0.070 |
Why?
|
| Animals | 24 | 2017 | 169337 | 0.070 |
Why?
|
| Models, Statistical | 4 | 2013 | 5099 | 0.060 |
Why?
|
| In Situ Hybridization | 2 | 2000 | 1905 | 0.060 |
Why?
|
| Alcohol Drinking | 6 | 2000 | 4049 | 0.060 |
Why?
|
| Vitamin D | 4 | 2015 | 3310 | 0.060 |
Why?
|
| Cardiomegaly | 2 | 1985 | 591 | 0.060 |
Why?
|
| Alleles | 6 | 2017 | 6892 | 0.060 |
Why?
|
| Proteoglycans | 1 | 2009 | 807 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2013 | 1346 | 0.060 |
Why?
|
| Amino Acid Sequence | 6 | 2001 | 13423 | 0.060 |
Why?
|
| Mental Health | 1 | 2000 | 3276 | 0.060 |
Why?
|
| Manganese | 2 | 2022 | 394 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2007 | 6034 | 0.060 |
Why?
|
| DNA Primers | 2 | 2008 | 2825 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2006 | 453 | 0.060 |
Why?
|
| Cardiotonic Agents | 1 | 2008 | 544 | 0.060 |
Why?
|
| Serpins | 1 | 2006 | 245 | 0.060 |
Why?
|
| DNA Helicases | 1 | 2010 | 853 | 0.060 |
Why?
|
| Adipose Tissue | 4 | 1997 | 3334 | 0.060 |
Why?
|
| Environmental Monitoring | 5 | 2010 | 1463 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 2750 | 0.060 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2005 | 167 | 0.060 |
Why?
|
| Trophoblasts | 1 | 2006 | 223 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2005 | 23631 | 0.060 |
Why?
|
| Telecommunications | 1 | 2004 | 79 | 0.060 |
Why?
|
| Neuropsychological Tests | 5 | 2016 | 7145 | 0.060 |
Why?
|
| Residence Characteristics | 2 | 2007 | 2122 | 0.060 |
Why?
|
| Solar Activity | 1 | 2024 | 44 | 0.060 |
Why?
|
| Protease Nexins | 3 | 2010 | 39 | 0.060 |
Why?
|
| Vitamin D Deficiency | 2 | 2012 | 1389 | 0.060 |
Why?
|
| Sympathetic Nervous System | 3 | 1996 | 521 | 0.060 |
Why?
|
| Vitamin B 12 | 3 | 2014 | 527 | 0.060 |
Why?
|
| Hyperuricemia | 1 | 2006 | 223 | 0.050 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2006 | 540 | 0.050 |
Why?
|
| Respiratory Tract Diseases | 2 | 1995 | 748 | 0.050 |
Why?
|
| Tars | 1 | 1983 | 20 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2009 | 1614 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2004 | 216 | 0.050 |
Why?
|
| Social Control, Formal | 1 | 1983 | 107 | 0.050 |
Why?
|
| Respiratory Hypersensitivity | 3 | 1990 | 272 | 0.050 |
Why?
|
| Likelihood Functions | 2 | 2007 | 993 | 0.050 |
Why?
|
| Plants, Toxic | 1 | 1983 | 70 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2009 | 790 | 0.050 |
Why?
|
| Genes, Recessive | 1 | 2005 | 625 | 0.050 |
Why?
|
| Therapy, Computer-Assisted | 2 | 2004 | 265 | 0.050 |
Why?
|
| Glucose Tolerance Test | 1 | 1986 | 1183 | 0.050 |
Why?
|
| T-Box Domain Proteins | 1 | 2005 | 473 | 0.050 |
Why?
|
| Motor Activity | 1 | 2013 | 2720 | 0.050 |
Why?
|
| Knee Joint | 1 | 2011 | 1686 | 0.050 |
Why?
|
| Kidney Diseases | 2 | 2004 | 2103 | 0.050 |
Why?
|
| Heart Diseases | 2 | 2006 | 2819 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2000 | 1141 | 0.050 |
Why?
|
| Hemochromatosis | 1 | 2004 | 176 | 0.050 |
Why?
|
| Epinephrine | 4 | 1994 | 794 | 0.050 |
Why?
|
| MADS Domain Proteins | 2 | 1999 | 19 | 0.050 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2004 | 982 | 0.050 |
Why?
|
| Computer Communication Networks | 1 | 2004 | 295 | 0.050 |
Why?
|
| GTPase-Activating Proteins | 2 | 2013 | 471 | 0.050 |
Why?
|
| Calcium | 2 | 2015 | 5794 | 0.050 |
Why?
|
| Endothelium, Vascular | 2 | 2011 | 4427 | 0.050 |
Why?
|
| Mitochondria | 1 | 2015 | 3675 | 0.050 |
Why?
|
| Comorbidity | 3 | 2016 | 10588 | 0.050 |
Why?
|
| Meningomyelocele | 1 | 2004 | 182 | 0.050 |
Why?
|
| Myocardium | 3 | 2000 | 4788 | 0.050 |
Why?
|
| Mortality | 3 | 2015 | 2917 | 0.050 |
Why?
|
| Prognosis | 9 | 2020 | 30022 | 0.050 |
Why?
|
| Housing | 2 | 2017 | 680 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2007 | 3252 | 0.050 |
Why?
|
| Lipids | 4 | 1999 | 3344 | 0.050 |
Why?
|
| Body Mass Index | 9 | 2015 | 13052 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2002 | 6241 | 0.050 |
Why?
|
| Risk Assessment | 9 | 2020 | 24318 | 0.050 |
Why?
|
| Water Supply | 1 | 1982 | 204 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2013 | 515 | 0.050 |
Why?
|
| Genome, Human | 2 | 2017 | 4450 | 0.050 |
Why?
|
| Vitamin B 6 | 2 | 2014 | 234 | 0.050 |
Why?
|
| Mites | 2 | 1998 | 46 | 0.050 |
Why?
|
| Transcription, Genetic | 4 | 2006 | 7599 | 0.050 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2000 | 75 | 0.040 |
Why?
|
| Motivation | 1 | 2010 | 2029 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2000 | 199 | 0.040 |
Why?
|
| Adaptation, Physiological | 2 | 2015 | 1315 | 0.040 |
Why?
|
| Bayes Theorem | 2 | 2022 | 2353 | 0.040 |
Why?
|
| Baroreflex | 1 | 2001 | 154 | 0.040 |
Why?
|
| Microtomy | 1 | 2000 | 44 | 0.040 |
Why?
|
| Blood Sedimentation | 1 | 1981 | 235 | 0.040 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2001 | 241 | 0.040 |
Why?
|
| Cause of Death | 2 | 2009 | 3728 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2007 | 2728 | 0.040 |
Why?
|
| Models, Structural | 1 | 2000 | 340 | 0.040 |
Why?
|
| Nuclear Proteins | 3 | 2016 | 5800 | 0.040 |
Why?
|
| Copper | 1 | 1982 | 369 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2016 | 3431 | 0.040 |
Why?
|
| Odds Ratio | 4 | 2015 | 9682 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 2000 | 699 | 0.040 |
Why?
|
| Psychotic Disorders | 1 | 2015 | 3279 | 0.040 |
Why?
|
| Ovum | 1 | 2000 | 187 | 0.040 |
Why?
|
| Urban Population | 4 | 2013 | 2045 | 0.040 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2000 | 156 | 0.040 |
Why?
|
| Cell Differentiation | 5 | 2001 | 11668 | 0.040 |
Why?
|
| Blood Glucose | 7 | 2009 | 6430 | 0.040 |
Why?
|
| Cholesterol | 4 | 2011 | 2912 | 0.040 |
Why?
|
| Self-Assessment | 1 | 2001 | 401 | 0.040 |
Why?
|
| Fertilization | 1 | 2000 | 198 | 0.040 |
Why?
|
| Vegetables | 2 | 2018 | 1198 | 0.040 |
Why?
|
| Type A Personality | 1 | 1998 | 24 | 0.040 |
Why?
|
| Tissue Distribution | 3 | 1998 | 2299 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2006 | 1371 | 0.040 |
Why?
|
| Self Disclosure | 1 | 2000 | 249 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 3520 | 0.040 |
Why?
|
| DNA | 3 | 2012 | 7211 | 0.040 |
Why?
|
| Eosinophilia | 2 | 1995 | 556 | 0.040 |
Why?
|
| Epigenomics | 2 | 2015 | 959 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2008 | 2812 | 0.040 |
Why?
|
| Two-Hybrid System Techniques | 1 | 1999 | 461 | 0.040 |
Why?
|
| Cataract | 1 | 2004 | 837 | 0.040 |
Why?
|
| Sulfates | 2 | 2011 | 379 | 0.040 |
Why?
|
| Cockroaches | 1 | 1998 | 92 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2005 | 5037 | 0.040 |
Why?
|
| Antigens, Dermatophagoides | 1 | 1998 | 102 | 0.040 |
Why?
|
| Germany | 1 | 2020 | 882 | 0.040 |
Why?
|
| Amphibians | 1 | 1997 | 29 | 0.040 |
Why?
|
| Somites | 1 | 1998 | 60 | 0.040 |
Why?
|
| Dopamine | 4 | 1994 | 1617 | 0.040 |
Why?
|
| Abattoirs | 1 | 2017 | 6 | 0.040 |
Why?
|
| Animal Welfare | 1 | 2017 | 19 | 0.040 |
Why?
|
| Home Care Services | 1 | 2004 | 659 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2006 | 1890 | 0.040 |
Why?
|
| Radiography | 4 | 2014 | 6993 | 0.040 |
Why?
|
| Culture Techniques | 1 | 1998 | 530 | 0.040 |
Why?
|
| Personality Inventory | 1 | 2000 | 1018 | 0.040 |
Why?
|
| Family Health | 3 | 2009 | 1255 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2000 | 1163 | 0.040 |
Why?
|
| Tail | 1 | 2017 | 90 | 0.040 |
Why?
|
| Desmosine | 1 | 1996 | 19 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2000 | 839 | 0.030 |
Why?
|
| Testis | 1 | 1980 | 783 | 0.030 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 1998 | 198 | 0.030 |
Why?
|
| Respiratory System | 2 | 1998 | 565 | 0.030 |
Why?
|
| Lod Score | 2 | 2009 | 600 | 0.030 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 1998 | 164 | 0.030 |
Why?
|
| Isoproterenol | 1 | 1997 | 398 | 0.030 |
Why?
|
| Endoderm | 1 | 1997 | 165 | 0.030 |
Why?
|
| Psychological Tests | 2 | 2012 | 643 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2000 | 1753 | 0.030 |
Why?
|
| Social Conditions | 1 | 1997 | 121 | 0.030 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 1998 | 308 | 0.030 |
Why?
|
| Ligases | 1 | 1998 | 333 | 0.030 |
Why?
|
| Speech | 1 | 2001 | 558 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2004 | 1424 | 0.030 |
Why?
|
| Serpin E2 | 2 | 2006 | 48 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2008 | 4526 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2000 | 2176 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2001 | 12805 | 0.030 |
Why?
|
| Ubiquitins | 1 | 1998 | 366 | 0.030 |
Why?
|
| Mutation | 4 | 2017 | 30228 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1999 | 1992 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 1997 | 382 | 0.030 |
Why?
|
| Body Height | 4 | 1991 | 1568 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2020 | 1221 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2001 | 1165 | 0.030 |
Why?
|
| Sarcoglycans | 1 | 2015 | 57 | 0.030 |
Why?
|
| Spermatozoa | 1 | 2000 | 631 | 0.030 |
Why?
|
| Nutrition Surveys | 2 | 2016 | 1736 | 0.030 |
Why?
|
| Weather | 2 | 2007 | 234 | 0.030 |
Why?
|
| Bone Density | 2 | 2006 | 3559 | 0.030 |
Why?
|
| Cell Line | 3 | 2005 | 15597 | 0.030 |
Why?
|
| Chickens | 1 | 1997 | 845 | 0.030 |
Why?
|
| Pedigree | 3 | 2009 | 4544 | 0.030 |
Why?
|
| Mice | 10 | 2011 | 82017 | 0.030 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2014 | 23 | 0.030 |
Why?
|
| Diabetes Mellitus | 3 | 2004 | 5891 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 4168 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2005 | 11120 | 0.030 |
Why?
|
| Water Pollutants, Chemical | 1 | 1999 | 362 | 0.030 |
Why?
|
| Parasympathetic Nervous System | 1 | 1995 | 144 | 0.030 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2014 | 56 | 0.030 |
Why?
|
| Spectrophotometry, Atomic | 2 | 2010 | 80 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 1999 | 717 | 0.030 |
Why?
|
| Alveolar Bone Loss | 1 | 1998 | 399 | 0.030 |
Why?
|
| Microsatellite Repeats | 2 | 2007 | 784 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2020 | 871 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2017 | 1769 | 0.030 |
Why?
|
| Pol1 Transcription Initiation Complex Proteins | 1 | 1994 | 8 | 0.030 |
Why?
|
| Age of Onset | 2 | 2013 | 3345 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2000 | 1209 | 0.030 |
Why?
|
| Nickel | 1 | 2015 | 126 | 0.030 |
Why?
|
| Muscle, Skeletal | 3 | 1999 | 4981 | 0.030 |
Why?
|
| Hand Strength | 1 | 1997 | 466 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2017 | 665 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 4775 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2003 | 3164 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2009 | 10776 | 0.030 |
Why?
|
| Catalase | 1 | 2014 | 215 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2013 | 1248 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2000 | 2069 | 0.030 |
Why?
|
| Follicle Stimulating Hormone | 2 | 1991 | 726 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2009 | 1568 | 0.030 |
Why?
|
| Binding Sites | 2 | 2000 | 6017 | 0.030 |
Why?
|
| Fishes | 1 | 1997 | 606 | 0.030 |
Why?
|
| Logistic Models | 7 | 2011 | 13323 | 0.030 |
Why?
|
| Calcium Channel Blockers | 2 | 2009 | 692 | 0.030 |
Why?
|
| Hippocampus | 1 | 2007 | 3784 | 0.030 |
Why?
|
| Anthropometry | 2 | 1995 | 1343 | 0.030 |
Why?
|
| Luteinizing Hormone | 2 | 1991 | 821 | 0.030 |
Why?
|
| Disease Susceptibility | 2 | 2017 | 1794 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 681 | 0.030 |
Why?
|
| Myosin Heavy Chains | 1 | 2015 | 404 | 0.030 |
Why?
|
| Heart Atria | 1 | 2000 | 1360 | 0.030 |
Why?
|
| Autopsy | 1 | 2017 | 1013 | 0.030 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2013 | 88 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 1999 | 1748 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2001 | 1943 | 0.030 |
Why?
|
| Handwriting | 1 | 2013 | 26 | 0.030 |
Why?
|
| Bronchodilator Agents | 1 | 1997 | 519 | 0.030 |
Why?
|
| Gout | 1 | 2000 | 621 | 0.030 |
Why?
|
| ROC Curve | 1 | 2001 | 3623 | 0.030 |
Why?
|
| Energy Intake | 2 | 2018 | 2145 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 1997 | 930 | 0.030 |
Why?
|
| Sleep, REM | 1 | 1996 | 595 | 0.030 |
Why?
|
| Myosins | 1 | 1994 | 407 | 0.030 |
Why?
|
| SRS-A | 1 | 1992 | 132 | 0.030 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1992 | 94 | 0.030 |
Why?
|
| Dyspnea | 1 | 2000 | 1351 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2018 | 1532 | 0.020 |
Why?
|
| ADAM Proteins | 1 | 2013 | 238 | 0.020 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2015 | 268 | 0.020 |
Why?
|
| Methylation | 1 | 2015 | 1076 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1980 | 2611 | 0.020 |
Why?
|
| Monitoring, Physiologic | 2 | 2013 | 1795 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2010 | 20765 | 0.020 |
Why?
|
| Nitrogen Dioxide | 1 | 2015 | 527 | 0.020 |
Why?
|
| Sex Factors | 3 | 2001 | 10654 | 0.020 |
Why?
|
| Valine | 1 | 2013 | 410 | 0.020 |
Why?
|
| Systole | 2 | 1984 | 937 | 0.020 |
Why?
|
| Gene Frequency | 2 | 2010 | 3617 | 0.020 |
Why?
|
| Acoustic Stimulation | 2 | 2013 | 1253 | 0.020 |
Why?
|
| Basophils | 1 | 1994 | 407 | 0.020 |
Why?
|
| Morbidity | 1 | 1997 | 1758 | 0.020 |
Why?
|
| Stroke | 2 | 2010 | 9742 | 0.020 |
Why?
|
| Hematocrit | 2 | 1983 | 625 | 0.020 |
Why?
|
| Drosophila | 1 | 1999 | 1514 | 0.020 |
Why?
|
| Neoplasms | 2 | 2010 | 22385 | 0.020 |
Why?
|
| Quality of Life | 2 | 2010 | 13503 | 0.020 |
Why?
|
| Metabolomics | 1 | 2020 | 1674 | 0.020 |
Why?
|
| Immunomodulation | 1 | 2015 | 549 | 0.020 |
Why?
|
| Predictive Value of Tests | 6 | 2013 | 15455 | 0.020 |
Why?
|
| 5-Methylcytosine | 1 | 2011 | 147 | 0.020 |
Why?
|
| Glycoproteins | 1 | 1998 | 2204 | 0.020 |
Why?
|
| Psychology | 1 | 2012 | 355 | 0.020 |
Why?
|
| Half-Life | 1 | 2011 | 650 | 0.020 |
Why?
|
| Conditioning, Classical | 1 | 2013 | 370 | 0.020 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2012 | 309 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 1996 | 809 | 0.020 |
Why?
|
| Exons | 2 | 2008 | 2392 | 0.020 |
Why?
|
| Respiratory Muscles | 1 | 1990 | 144 | 0.020 |
Why?
|
| Skinfold Thickness | 2 | 1997 | 164 | 0.020 |
Why?
|
| Nutritional Status | 1 | 1998 | 1627 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1999 | 2421 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2011 | 646 | 0.020 |
Why?
|
| Chronic Disease | 3 | 2004 | 9379 | 0.020 |
Why?
|
| Mucus | 1 | 1991 | 346 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 2013 | 494 | 0.020 |
Why?
|
| Age Distribution | 2 | 2007 | 2877 | 0.020 |
Why?
|
| Serum Albumin | 1 | 1992 | 676 | 0.020 |
Why?
|
| Retirement | 2 | 1996 | 198 | 0.020 |
Why?
|
| Triglycerides | 3 | 2011 | 2465 | 0.020 |
Why?
|
| Bronchial Spasm | 1 | 1989 | 71 | 0.020 |
Why?
|
| Heart Block | 1 | 2011 | 390 | 0.020 |
Why?
|
| Untranslated Regions | 1 | 2008 | 30 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 1990 | 417 | 0.020 |
Why?
|
| Adolescent | 5 | 2015 | 89184 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2010 | 375 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2009 | 89 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 65379 | 0.020 |
Why?
|
| Awareness | 1 | 2013 | 653 | 0.020 |
Why?
|
| Haplotypes | 2 | 2005 | 2724 | 0.020 |
Why?
|
| Environmental Health | 1 | 2011 | 295 | 0.020 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2009 | 146 | 0.020 |
Why?
|
| Kidney | 3 | 2004 | 7064 | 0.020 |
Why?
|
| Prevalence | 3 | 2017 | 15872 | 0.020 |
Why?
|
| Residual Volume | 1 | 1988 | 40 | 0.020 |
Why?
|
| Meteorological Concepts | 1 | 2008 | 30 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2009 | 272 | 0.020 |
Why?
|
| Saliva | 1 | 2013 | 854 | 0.020 |
Why?
|
| Collagen | 1 | 1996 | 2646 | 0.020 |
Why?
|
| Sequence Analysis | 1 | 2008 | 240 | 0.020 |
Why?
|
| Gene Expression Regulation | 4 | 2015 | 11918 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1998 | 2890 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 9510 | 0.020 |
Why?
|
| Hemodynamics | 2 | 1996 | 4199 | 0.020 |
Why?
|
| Sulfur | 1 | 2008 | 160 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2005 | 12241 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2000 | 3838 | 0.020 |
Why?
|
| Protein C | 1 | 1987 | 134 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2007 | 6876 | 0.020 |
Why?
|
| Air Movements | 1 | 2007 | 40 | 0.020 |
Why?
|
| Nasopharynx | 1 | 1990 | 420 | 0.020 |
Why?
|
| Fasting | 3 | 1998 | 1610 | 0.020 |
Why?
|
| Swine | 1 | 2017 | 5994 | 0.020 |
Why?
|
| Thyrotropin | 1 | 1991 | 834 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2015 | 1422 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2008 | 318 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2015 | 2127 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2004 | 4713 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2017 | 2598 | 0.020 |
Why?
|
| Arousal | 1 | 1992 | 1183 | 0.020 |
Why?
|
| Child | 7 | 2015 | 80891 | 0.020 |
Why?
|
| Dietary Fats | 1 | 1994 | 2003 | 0.020 |
Why?
|
| Inositol | 1 | 2007 | 216 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2013 | 8731 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2009 | 620 | 0.020 |
Why?
|
| Placentation | 1 | 2006 | 78 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2016 | 3230 | 0.020 |
Why?
|
| Seafood | 1 | 2009 | 395 | 0.020 |
Why?
|
| Methionine | 1 | 2008 | 573 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2005 | 1244 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2009 | 891 | 0.020 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2005 | 44 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 1996 | 1597 | 0.020 |
Why?
|
| Anesthesia, General | 1 | 1992 | 1186 | 0.020 |
Why?
|
| Abdomen | 2 | 1994 | 1136 | 0.020 |
Why?
|
| Thrombin | 1 | 1987 | 600 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2010 | 1998 | 0.010 |
Why?
|
| Apolipoproteins B | 1 | 1986 | 386 | 0.010 |
Why?
|
| Choline | 1 | 2007 | 518 | 0.010 |
Why?
|
| Oxidants, Photochemical | 1 | 2005 | 77 | 0.010 |
Why?
|
| Epoxy Compounds | 1 | 2005 | 137 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 1727 | 0.010 |
Why?
|
| Creatine | 1 | 2007 | 427 | 0.010 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 166 | 0.010 |
Why?
|
| Models, Biological | 2 | 2011 | 9493 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 2007 | 577 | 0.010 |
Why?
|
| Receptors, LDL | 1 | 1986 | 491 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 1 | 2005 | 265 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2017 | 6277 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2009 | 2931 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2016 | 3203 | 0.010 |
Why?
|
| Fruit | 1 | 2009 | 1164 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2016 | 3587 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2004 | 348 | 0.010 |
Why?
|
| Thorax | 1 | 1986 | 559 | 0.010 |
Why?
|
| Urban Health | 1 | 2005 | 535 | 0.010 |
Why?
|
| Metacarpus | 1 | 1982 | 37 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 18362 | 0.010 |
Why?
|
| Epidemiologic Methods | 2 | 1986 | 1337 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 2003 | 267 | 0.010 |
Why?
|
| Algorithms | 3 | 2013 | 14154 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 1742 | 0.010 |
Why?
|
| Sacrum | 1 | 2004 | 275 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2862 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 1986 | 646 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 3712 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2010 | 4622 | 0.010 |
Why?
|
| Protons | 1 | 2007 | 1112 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13646 | 0.010 |
Why?
|
| Physical Chromosome Mapping | 1 | 2001 | 183 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2006 | 722 | 0.010 |
Why?
|
| Maximal Expiratory Flow-Volume Curves | 1 | 2000 | 25 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1982 | 326 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2007 | 1752 | 0.010 |
Why?
|
| Cell Fusion | 1 | 2001 | 294 | 0.010 |
Why?
|
| Survival Rate | 1 | 2015 | 12870 | 0.010 |
Why?
|
| Blood Volume | 1 | 1982 | 546 | 0.010 |
Why?
|
| Vasopressins | 1 | 1982 | 358 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 2004 | 737 | 0.010 |
Why?
|
| Calcineurin | 1 | 2001 | 236 | 0.010 |
Why?
|
| Peptide Fragments | 2 | 1990 | 5151 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 1980 | 195 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 1991 | 2083 | 0.010 |
Why?
|
| Bronchography | 1 | 1999 | 74 | 0.010 |
Why?
|
| Education | 1 | 2002 | 535 | 0.010 |
Why?
|
| Cell Size | 1 | 2001 | 626 | 0.010 |
Why?
|
| NFATC Transcription Factors | 1 | 2001 | 393 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2004 | 1837 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 2004 | 1390 | 0.010 |
Why?
|
| Family | 1 | 2010 | 3208 | 0.010 |
Why?
|
| Trachea | 2 | 1999 | 1095 | 0.010 |
Why?
|
| Bone Remodeling | 1 | 2002 | 583 | 0.010 |
Why?
|
| Dental Health Surveys | 1 | 1998 | 39 | 0.010 |
Why?
|
| Sensation | 1 | 2000 | 337 | 0.010 |
Why?
|
| Ascorbic Acid Deficiency | 1 | 1998 | 26 | 0.010 |
Why?
|
| Interleukins | 1 | 2003 | 796 | 0.010 |
Why?
|
| SUMO-1 Protein | 1 | 1998 | 35 | 0.010 |
Why?
|
| Medical Record Linkage | 1 | 1999 | 286 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2004 | 2524 | 0.010 |
Why?
|
| Pulse | 3 | 1982 | 218 | 0.010 |
Why?
|
| Syndrome | 1 | 2004 | 3275 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3695 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2002 | 2281 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3794 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 4353 | 0.010 |
Why?
|
| Hand | 1 | 1982 | 912 | 0.010 |
Why?
|
| Placenta | 1 | 2006 | 1723 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2007 | 3781 | 0.010 |
Why?
|
| Sleep | 1 | 1992 | 4802 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2001 | 1967 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2001 | 1176 | 0.010 |
Why?
|
| Pollen | 1 | 1996 | 80 | 0.010 |
Why?
|
| Protein Transport | 1 | 2001 | 1958 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 4120 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1995 | 363 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 1998 | 658 | 0.010 |
Why?
|
| Eosinophils | 2 | 1990 | 953 | 0.010 |
Why?
|
| Weight Gain | 1 | 2005 | 2356 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1995 | 1056 | 0.010 |
Why?
|
| Gastrula | 1 | 1994 | 83 | 0.010 |
Why?
|
| Health Surveys | 1 | 2004 | 4056 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2004 | 2337 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1995 | 1086 | 0.010 |
Why?
|
| MyoD Protein | 1 | 1994 | 141 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2005 | 20224 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 4357 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1995 | 1065 | 0.010 |
Why?
|
| Genomics | 1 | 2009 | 5916 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 1996 | 594 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 1998 | 762 | 0.010 |
Why?
|
| Estradiol | 1 | 1980 | 1952 | 0.010 |
Why?
|
| Dust | 1 | 1996 | 488 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 8051 | 0.010 |
Why?
|
| Death, Sudden | 1 | 1994 | 301 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2001 | 14737 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 1999 | 1320 | 0.010 |
Why?
|
| Leukotriene E4 | 1 | 1992 | 75 | 0.010 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 1992 | 144 | 0.010 |
Why?
|
| Vasodilation | 1 | 1996 | 968 | 0.010 |
Why?
|
| Positive-Pressure Respiration | 1 | 1996 | 713 | 0.010 |
Why?
|
| Albuterol | 1 | 1992 | 211 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1995 | 2475 | 0.010 |
Why?
|
| Blastocyst | 1 | 1994 | 432 | 0.010 |
Why?
|
| Thermoreceptors | 1 | 1990 | 27 | 0.010 |
Why?
|
| Mechanoreceptors | 1 | 1992 | 194 | 0.010 |
Why?
|
| Income | 1 | 1999 | 1877 | 0.010 |
Why?
|
| Levodopa | 1 | 1991 | 223 | 0.010 |
Why?
|
| Wound Healing | 1 | 2001 | 2813 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 1992 | 498 | 0.010 |
Why?
|
| Mothers | 1 | 2000 | 2211 | 0.010 |
Why?
|
| Testosterone | 1 | 1980 | 2493 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1995 | 3088 | 0.010 |
Why?
|
| Airway Resistance | 1 | 1990 | 406 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1998 | 3731 | 0.010 |
Why?
|
| Crystallization | 1 | 1990 | 521 | 0.000 |
Why?
|
| Cough | 1 | 1993 | 599 | 0.000 |
Why?
|
| Prolactin | 1 | 1991 | 626 | 0.000 |
Why?
|
| Retrospective Studies | 3 | 2006 | 81801 | 0.000 |
Why?
|
| Growth Hormone | 1 | 1991 | 573 | 0.000 |
Why?
|
| Glucose | 1 | 1980 | 4352 | 0.000 |
Why?
|
| Fibrinopeptide A | 1 | 1987 | 43 | 0.000 |
Why?
|
| Dietary Carbohydrates | 1 | 1992 | 896 | 0.000 |
Why?
|
| Receptors, Thrombin | 1 | 1987 | 130 | 0.000 |
Why?
|
| Cholesterol, HDL | 1 | 1994 | 1820 | 0.000 |
Why?
|
| Dietary Proteins | 1 | 1992 | 960 | 0.000 |
Why?
|
| Prothrombin | 1 | 1987 | 193 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1995 | 2886 | 0.000 |
Why?
|
| Apolipoproteins A | 1 | 1986 | 96 | 0.000 |
Why?
|
| Carbon Dioxide | 1 | 1990 | 1149 | 0.000 |
Why?
|
| Apolipoprotein B-100 | 1 | 1986 | 157 | 0.000 |
Why?
|
| Mice, Knockout | 1 | 2001 | 14481 | 0.000 |
Why?
|
| Data Interpretation, Statistical | 1 | 1995 | 2708 | 0.000 |
Why?
|
| Electromyography | 1 | 1990 | 1402 | 0.000 |
Why?
|
| Recurrence | 1 | 1978 | 8506 | 0.000 |
Why?
|
| Apolipoprotein A-I | 1 | 1986 | 305 | 0.000 |
Why?
|
| Hemostasis | 1 | 1987 | 468 | 0.000 |
Why?
|
| Glucosides | 1 | 1990 | 533 | 0.000 |
Why?
|
| Aspirin | 1 | 1996 | 3135 | 0.000 |
Why?
|
| Cholesterol, LDL | 1 | 1994 | 2398 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1996 | 3579 | 0.000 |
Why?
|
| Polyethylene Glycols | 1 | 1990 | 1195 | 0.000 |
Why?
|
| Pregnancy | 1 | 2006 | 30200 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2004 | 26411 | 0.000 |
Why?
|
| Protein Binding | 1 | 1995 | 9343 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2001 | 15939 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1995 | 10117 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2005 | 42650 | 0.000 |
Why?
|
| Oligopeptides | 1 | 1987 | 1194 | 0.000 |
Why?
|
| Acute Disease | 1 | 1992 | 7242 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1982 | 657 | 0.000 |
Why?
|
| Anesthesia | 1 | 1990 | 1596 | 0.000 |
Why?
|
| Life Change Events | 1 | 1984 | 962 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1986 | 3955 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1992 | 6317 | 0.000 |
Why?
|
| Kinetics | 1 | 1980 | 6333 | 0.000 |
Why?
|